Stock DC8A DURECT CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Calendar DURECT Corporation Deutsche Boerse AG

Equities

DC8A

US2666055007

Market Closed - Deutsche Boerse AG
Other stock markets
 01:08:56 08/06/2024 am IST 		5-day change 1st Jan Change
1.33 EUR -2.92% Intraday chart for DURECT Corporation +9.92% +153.33%
21/05 DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis CI
21/05 Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon MT

Chart calendar DURECT Corporation

d.wHUVxyGj3fKG2NCuuVg9c1z07SvWPjDMBfQSyouns88.9Th2kHCW8KXLio_q3WtlJzuw3HqzS3mlbLl9p6bGi4CMLEfzRvW0wd63ow~b109589a307d4d715234701779f6641b

Upcoming events on DURECT Corporation

01/08/2024 Q2 2024 Earnings Release (Projected)
04/11/2024 Q3 2024 Earnings Release (Projected)
11/03/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on DURECT Corporation

08/06/2024 06:00 pm European Association for the Study of the Liver Congress - Abstract No. LB73
14/05/2024 02:00 am Q1 2024 Earnings Call
14/05/2024 01:35 am Q1 2024 Earnings Release
28/03/2024 02:00 am Q4 2023 Earnings Call
28/03/2024 01:35 am Q4 2023 Earnings Release
14/02/2024 09:10 pm Oppenheimer Healthcare Life Sciences Conference
14/11/2023 03:00 am Q3 2023 Earnings Call
14/11/2023 02:35 am Q3 2023 Earnings Release
08/11/2023 03:30 am Business Update Call
28/09/2023 02:15 am Cantor Global Healthcare Conference
11/09/2023 08:00 pm H.C. Wainwright Global Investment Conference
10/08/2023 02:00 am Q2 2023 Earnings Call
10/08/2023 01:35 am Q2 2023 Earnings Release
21/06/2023 09:30 pm Annual General Meeting
16/05/2023 09:30 pm Investor Meeting - Key Opinion Leader
09/05/2023 02:00 am Q1 2023 Earnings Call
09/05/2023 01:35 am Q1 2023 Earnings Release
02/05/2023 07:30 pm H.C. Wainwright BioConnect Investor Conference
15/03/2023 11:30 pm Oppenheimer Healthcare Conference
08/03/2023 03:00 am Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		29,6
29,8
-0.84%		30,1
40,4
-25.4%		14,0
8,79
59.07%		19,3
19,5
-0.91%		8,55
8,58
-0.38%
10,1

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-19,2
-18,2
-5.19%		-12,6
-6,40
-97.24%		-34,3
-38,3
10.59%		-35,1
-35,6
1.32%		-36,9
-40,3
8.41%
-25,9

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-20,6
-19,9
-3.36%		-14,3
-6,90
-107.67%		-36,3
-40,2
9.74%		-35,3
-37,4
5.43%		-27,6
-37,8
26.82%
-28,3

Net income
Million USD		Released
Forecast
Spread 		-20,6
-19,9
-3.36%		-0,58
-8,07
92.78%		-36,3
-40,2
9.74%		-35,3
-37,3
5.36%		-27,6
-37,9
27.16%
-28,8

EPS
USD		Released
Forecast
Spread 		-1,20
-1,14
-5.26%		0,00
-0,40
- 		-1,60
-1,80
11.11%		-1,55
-1,15
-34.78%		-1,05
-1,46
28.25%
-0,85

Announcement Date03/03/2004/03/2107/03/2207/03/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		1,92
2,28
-16.13%		2,08
3,84
-45.98%		12,0
13,0
-7.78%		3,32
3,48
-4.78%		2,05
3,19
-35.52%		2,08
3,16
-34.12%		1,74
2,52
-30.74%		2,67
2,70
-1.22%		1,83
2,73
-32.95%
2,49


2,56


2,73

EBIT
Million USD		Released
Forecast
Spread 		-10,4
-11,9
13.21%		-11,1
-10,4
-7.1%		-2,13
-2,29
6.85%		-11,5
-12,0
3.88%		-11,0
-12,5
11.98%		-10,1
-11,2
10.09%		-9,56
-10,6
10.17%		-6,25
-9,64
35.12%		-5,72
-6,34
9.77%
-5,48


-6,33


-8,87

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-10,8
-12,3
11.79%		-11,6
-10,9
-6.27%		-2,47
-2,81
12.02%		-10,5
-12,5
16.15%		-12,0
-12,9
7.16%		-11,2
-11,7
4.18%		-3,02
-10,8
71.96%		-1,44
-8,88
83.78%		-7,64
-6,65
-15%
-5,55


-6,45


-9,44

Net income
Million USD		Released
Forecast
Spread 		-10,8
-12,3
11.79%		-11,6
-10,9
-6.27%		-2,47
-2,81
12.02%		-10,5
-12,5
16.15%		-12,0
-12,9
7.16%		-11,2
-11,7
4.18%		-3,02
-11,0
72.47%		-1,44
-9,96
85.53%		-7,64
-6,65
-15%
-5,80


-6,69


-9,22

EPS
USD		Released
Forecast
Spread 		-0,50
-0,53
6.25%		-0,50
-0,47
-7.14%		-0,10
-0,10
0%		-0,46
-0,55
15.85%		-0,50
-0,53
5.06%		-0,46
-0,48
4.83%		-0,11
-0,41
73.39%		-0,05
-0,36
86.11%		-0,25
-0,22
-13.64%
-0,17


-0,20


-0,26

Announcement Date04/05/2204/08/2202/11/2207/03/2308/05/2309/08/2313/11/2327/03/2413/05/24---

Upcoming sector events for DURECT Corporation

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for DURECT Corporation

05/06/2024 01:21 pm PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. DRRX Stock
  4. DC8A Stock
  5. Calendar DURECT Corporation